Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...
News-Medical.Net on MSN
Single-cell technique maps pre-malignant gene mutations in solid tissues
A new single-cell profiling technique has mapped pre-malignant gene mutations and their effects in solid tissues for the ...
Scientists have developed a blood test that can help predict which breast cancer treatment will work best. The team at the ...
For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.
A rare form of diabetes affecting newborn babies and caused by a genetic disorder has been discovered by scientists in the UK ...
Researchers often use a nematode worm called Caenorhabditis elegans (C. elegans) to study human genetics .. | Cell And ...
Researchers say their clinical trial is the first to show that personalized drug treatments based on tumor DNA are safe and ...
Weekly Trust on MSN
When DNA results don’t tell the whole story
The truth is that, while DNA testing is often touted as being 99.9% accurate, that tiny remaining fraction is where thousands ...
Genetic disorders occur due to alterations in the primary genetic material—deoxyribonucleic acid (DNA)—of an organism.
Researchers developed a single-cell sequencing method that simultaneously measures cancer-linked DNA mutations and gene activity in solid tissues. Applying the approach to human esophageal samples ...
News-Medical.Net on MSN
Resistance to rezatapopt: New TP53 mutations identified in cancer patients
Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...
The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results